Table of Contents:

1 Introduction    8
1.1 Industry Definition and Research Scope    8
1.1.1 Industry Definition    8
1.1.2 Research Scope    9
1.2 Research Methodology    12
1.2.1 Overview of Market Research Methodology    12
1.2.2 Market Assumption    13
1.2.3 Secondary Data    13
1.2.4 Primary Data    13
1.2.5 Data Filtration and Model Design    14
1.2.6 Market Size/Share Estimation    15
1.2.7 Research Limitations    16
1.3 Executive Summary    17
2 Market Overview and Dynamics    21
2.1 Market Size and Forecast    21
2.1.1 Impact of COVID-19 on World Economy    23
2.1.2 Impact of COVID-19 on the Market    26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery    28
2.2 Major Growth Drivers    32
2.3 Market Restraints and Challenges    39
2.4 Emerging Opportunities and Market Trends    42
2.5 Porter’s Fiver Forces Analysis    46
3 Segmentation of Switzerland Market by Product Category    50
3.1 Market Overview by Product Category    50
3.2 Trials of Drugs    52
3.2.1 Small Molecule Drugs    53
3.2.2 Vaccines    54
3.2.3 Cell & Gene Therapy    55
3.2.4 Other Drugs    56
3.3 Trials of Devices    57
3.4 Trials of Procedures    58
4 Segmentation of Switzerland Market by Phase    59
4.1 Market Overview by Phase    59
4.2 Phase I    61
4.3 Phase II    62
4.4 Phase III    63
4.5 Phase IV    64
5 Segmentation of Switzerland Market by Design    65
5.1 Market Overview by Design    65
5.2 Interventional Studies    67
5.2.1 Randomized Control Trial    69
5.2.2 Adaptive Clinical Trial    70
5.2.3 Non-randomized Control Trial    71
5.3 Observational Studies    72
5.3.1 Cohort Study    74
5.3.2 Case Control Study    75
5.3.3 Cross Sectional Study    76
5.3.4 Ecological Study    77
5.4 Expanded Access Trials    78
6 Segmentation of Switzerland Market by Service Type    79
6.1 Market Overview by Service Type    79
6.2 Protocol Designing    81
6.3 Site Identification    82
6.4 Patient Recruitment    83
6.5 Laboratory Services    84
6.6 Bioanalytical Testing Services    85
6.7 Clinical Trial Data Management Services    86
6.8 Clinical Trial Supply & Logistic Services    87
6.9 Decentralized Clinical Trial Services    88
6.10 Medical Device Testing Services    89
6.11 Other Clinical Trial Services    90
7 Segmentation of Switzerland Market by Indication    91
7.1 Market Overview by Indication    91
7.2 Oncology    93
7.3 Infectious Diseases    95
7.4 Cardiology    96
7.5 Obesity    97
7.6 Diabetes    98
7.7 Neurology    99
7.8 Immunology    100
7.9 Pain Management    101
7.10 Other Indications    102
8 Segmentation of Switzerland Market by End User    103
8.1 Market Overview by End User    103
8.2 Pharmaceutical and Biotechnological Companies    105
8.3 Clinical Research Organizations    106
8.4 Clinical Testing Laboratories    107
8.5 Other End Users    108
9 Segmentation of Switzerland Market by Region    109
10 Competitive Landscape    111
10.1 Overview of Key Vendors    111
10.2 New Product Launch, Partnership, Investment, and M&A    114
10.3 Company Profiles    115
Accell Clinical Research LLC    115
Charles River Laboratories    117
ClinDatrix Inc    120
Clinipace    121
Eli Lilly and Company    123
F. Hoffmann-La Roche Ltd.    126
ICON PLC    129
IQVIA Holdings, Inc.    132
Laboratory Corporation of America (Covance Inc.)    136
Novo Nordisk AS    140
PAREXEL International Corporation    143
Pfizer Inc.    147
Pharmaceutical Product Development LLC    152
Phlexglobal    155
PRA Health Sciences    157
Sanofi SA    159
SGS SA (SGS Life Sciences)    162
Syneos Health Inc.    165
Wuxi AppTec Inc.    168
RELATED REPORTS    170

List of Tables:

Table 1. Snapshot of Switzerland Clinical Trials Market in Balanced Perspective, 2022-2031    18
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021    22
Table 3. World Economic Outlook, 2021-2031    24
Table 4. World Economic Outlook, 2021-2023    25
Table 5. Scenarios for Economic Impact of Ukraine Crisis    29
Table 6. World Health Spending by Region, $ bn, 2013-2020    38
Table 7. Main Product Trends and Market Opportunities in Switzerland Clinical Trials Market    42
Table 8. Switzerland Clinical Trials Market by Product Category, 2021-2031, $ mn    50
Table 9. Switzerland Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn    52
Table 10. Switzerland Clinical Trials Market by Phase, 2021-2031, $ mn    59
Table 11. Switzerland Clinical Trials Market by Design, 2021-2031, $ mn    65
Table 12. Switzerland Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn    68
Table 13. Switzerland Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn    73
Table 14. Switzerland Clinical Trials Market by Service Type, 2021-2031, $ mn    79
Table 15. Switzerland Clinical Trials Market by Indication, 2021-2031, $ mn    91
Table 16. Number of Oncology Clinical Trials and Number of Patients in Switzerland by Cancer Type, as of March 2023    94
Table 17. Switzerland Clinical Trials Market by End User, 2021-2031, $ mn    103
Table 18. Switzerland Clinical Trials Market by Region, 2021-2031, % of Revenue    109
Table 19. Switzerland Clinical Trials Market by Region, 2021-2031, $ mn    110
Table 20. Accell Clinical Research LLC: Company Snapshot    115
Table 21. Accell Clinical Research LLC: Business Segmentation    116
Table 22. Accell Clinical Research LLC: Product Portfolio    116
Table 23. Charles River Laboratories: Company Snapshot    117
Table 24. Charles River Laboratories: Product Portfolio    118
Table 25. Charles River Laboratories: Breakdown of Revenue by Division    118
Table 26. Charles River Laboratories: Breakdown of Revenue by Region    119
Table 27. ClinDatrix Inc: Company Snapshot    120
Table 28. Clinipace: Company Snapshot    121
Table 29. Clinipace: Product Portfolio    122
Table 30. Eli Lilly and Company: Company Snapshot    123
Table 31. Eli Lilly and Company: Pharmaceutical Brands    124
Table 32. Eli Lilly and Company: Clinical Trial Service    124
Table 33. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area    124
Table 34. Eli Lilly and Company: Breakdown of Revenue by Region    125
Table 35. F. Hoffmann-La Roche: Company Snapshot    126
Table 36. F. Hoffmann-La Roche: Clinical Trial Service    126
Table 37. F. Hoffmann-La Roche: Business Segmentation    127
Table 38. F. Hoffmann-La Roche: Revenue by Region    127
Table 39. ICON Plc: Company Snapshot    129
Table 40. ICON Plc: Business Segmentation    129
Table 41. ICON Plc: Product Portfolio    130
Table 42. ICON Plc: Revenue by Region, 2020, 0
Table 43. IQVIA Holdings Inc.: Company Snapshot    132
Table 44. IQVIA Holdings Inc.: Business Segmentation    133
Table 45. IQVIA Holdings Inc.: Revenue by Region, 2020, 3
Table 46. IQVIA Holdings Inc.: Product Portfolio    134
Table 47. Covance Inc.: Company Snapshot    136
Table 48. Covance Inc.: Product Portfolio    137
Table 49. Covance Inc.: Revenue by Region, 2020, 8
Table 50. Novo Nordisk: Company Snapshot    140
Table 51. Novo Nordisk: Product Portfolio    141
Table 52. Novo Nordisk: Breakdown of Revenue by Business Segment    142
Table 53. Novo Nordisk: Breakdown of Revenue by Region    142
Table 54. PAREXEL International Corporation: Company Snapshot    143
Table 55. PAREXEL International Corporation: Business Segmentation    144
Table 56. PAREXEL International Corporation: Revenue by Region, 2018, 4
Table 57. PAREXEL International Corporation: Product Portfolio    145
Table 58. Pfizer Inc.: Company Snapshot    147
Table 59. Pfizer Inc.: Business Segmentation    148
Table 60. Pfizer Inc.: Breakdown of Revenue by Product Category    148
Table 61. Pfizer Inc.: Breakdown of Revenue by Region    149
Table 62. Pfizer Inc.: Product Portfolio    149
Table 63. Pfizer Inc.: Revenue, 2018-2020, $ bn    150
Table 64. Pharmaceutical Product Development LLC (PPD): Company Snapshot    152
Table 65. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division    153
Table 66. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region    153
Table 67. Phlexglobal: Company Snapshot    155
Table 68. PRA Health Sciences Inc.: Company Snapshot    157
Table 69. PRA Health Sciences Inc.: Business Segmentation    158
Table 70. PRA Health Sciences Inc.: Revenue by Region, 2018, 8
Table 71. Sanofi: Company Snapshot    159
Table 72. Sanofi: Business Segmentation    160
Table 73. Sanofi: Breakdown of Revenue by Region    160
Table 74. SGS SA (SGS Life Sciences): Company Snapshot    162
Table 75. SGS SA (SGS Life Sciences): Business Segmentation    163
Table 76. SGS SA (SGS Life Sciences): Revenue by Region, 2018, 3
Table 77. Syneos Health Inc.: Company Snapshot    165
Table 78. Syneos Health Inc.: Business Segmentation    166
Table 79. Syneos Health Inc.: Revenue by Region, 2020, 6
Table 80. WuXi AppTec Inc.: Company Snapshot    168

List of Figures:

Figure 1. Research Method Flow Chart    12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    15
Figure 3. Switzerland Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031    17
Figure 4. Switzerland Clinical Trials Market, 2021-2031, $ mn    21
Figure 5. Impact of COVID-19 on Business    26
Figure 6. Primary Drivers and Impact Factors of Switzerland Clinical Trials Market    32
Figure 7. Percentage of Trial Participants by Country, 2015-2019    35
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million    36
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    37
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060    37
Figure 11. Primary Restraints and Impact Factors of Switzerland Clinical Trials Market    39
Figure 12. Investment Opportunity Analysis    43
Figure 13. Porter’s Fiver Forces Analysis of Switzerland Clinical Trials Market    46
Figure 14. Breakdown of Switzerland Clinical Trials Market by Product Category, 2021-2031, % of Revenue    51
Figure 15. Switzerland Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)    51
Figure 16. Switzerland Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn    52
Figure 17. Switzerland Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn    53
Figure 18. Switzerland Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn    54
Figure 19. Switzerland Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn    55
Figure 20. Switzerland Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn    56
Figure 21. Switzerland Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn    57
Figure 22. Switzerland Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn    58
Figure 23. Breakdown of Switzerland Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue    60
Figure 24. Switzerland Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)    60
Figure 25. Switzerland Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn    61
Figure 26. Switzerland Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn    62
Figure 27. Switzerland Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn    63
Figure 28. Switzerland Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn    64
Figure 29. Breakdown of Switzerland Clinical Trials Market by Design, 2021-2031, % of Sales Revenue    66
Figure 30. Switzerland Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)    66
Figure 31. Switzerland Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn    67
Figure 32. Switzerland Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn    69
Figure 33. Switzerland Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn    70
Figure 34. Switzerland Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn    71
Figure 35. Switzerland Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn    72
Figure 36. Switzerland Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn    74
Figure 37. Switzerland Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn    75
Figure 38. Switzerland Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn    76
Figure 39. Switzerland Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn    77
Figure 40. Switzerland Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn    78
Figure 41. Breakdown of Switzerland Clinical Trials Market by Service Type, 2021-2031, % of Revenue    80
Figure 42. Switzerland Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)    80
Figure 43. Switzerland Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn    81
Figure 44. Switzerland Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn    82
Figure 45. Switzerland Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn    83
Figure 46. Switzerland Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn    84
Figure 47. Switzerland Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn    85
Figure 48. Switzerland Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn    86
Figure 49. Switzerland Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn    87
Figure 50. Switzerland Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn    88
Figure 51. Switzerland Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn    89
Figure 52. Switzerland Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn    90
Figure 53. Breakdown of Switzerland Clinical Trials Market by Indication, 2021-2031, % of Revenue    92
Figure 54. Switzerland Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)    92
Figure 55. Switzerland Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn    93
Figure 56. Switzerland Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn    95
Figure 57. Switzerland Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn    96
Figure 58. Switzerland Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn    97
Figure 59. Switzerland Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn    98
Figure 60. Switzerland Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn    99
Figure 61. Switzerland Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn    100
Figure 62. Switzerland Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn    101
Figure 63. Switzerland Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn    102
Figure 64. Breakdown of Switzerland Clinical Trials Market by End User, 2021-2031, % of Revenue    103
Figure 65. Switzerland Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)    104
Figure 66. Switzerland Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn    105
Figure 67. Switzerland Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn    106
Figure 68. Switzerland Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn    107
Figure 69. Switzerland Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn    108
Figure 70. Growth Stage of Switzerland Clinical Trials Industry over the Forecast Period    111

Selected Key Players: 

Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexSwitzerland
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)